MHC will be closed for the Holidays on December 24-25, 2024, and December 31, 2024, through January 1, 2025. Insulated pharmaceuticals will be shipped through December 18, 2024. Standard two-day shipping will resume on January 6, 2025. For inquiries about overnight shipments, please reach out to your representative.
Use this bar to show information about your cookie policy.
Description
RYZUMVI (Phentolamine Ophthalmic Solution) 0.75% is indicated for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g.phenylephrine) or parasympatholytic (e.g.tropicamide) agents. The only available FDA-approved treatment for the reversal of pharmacologically-induced mydriasis.
